Hemodynamic data and survival in children with pulmonary hypertension

Journal of the American College of Cardiology

Volumn 30, Issue 2, 1997, Pages 554-560

  Clabby, Martha L ^a   Canter, Charles E ^a   Moller, James H ^b   Bridges, Nancy D ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DATA ANALYSIS; FEMALE; HEART INDEX; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGRESSION ANALYSIS; SURVIVAL RATE;

BLOOD PRESSURE; CHILD; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; REGRESSION ANALYSIS; SURVIVAL RATE; VASCULAR RESISTANCE;

EID: 0030802871     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00155-1     Document Type: Article

References (24)

1. Thilenius OG, Nadas AS, Jockin H. Primary pulmonary vascular obstruction in children. Pediatrics. 36:1965;75-87.
2. Cartmill TB, DuShane JW, McGoon DC, Kirklin JW. Results of repair of ventricular septal defect. J Thorac Cardiovasc Surg 1966;52:486-50.
3. Clarkson PM, Frye RL, DuShane JW, Burchell HB, Wood EH, Weidman WH. Prognosis for patients with ventricular septal defect and severe pulmonary vascular obstructive disease. Circulation. 38:1968;129-135.
4. Blackstone EH, Kirklin JW, Bradley EL, DuShane JW, Applebaum A. Optimal age and results of repair of large ventricular septal defects. J Thorac Cardiovasc Surg. 72:1976;661-679.
5. D'Alonzo GE, Barst RJ, Ayers SM, et al. Survival in patients with primary pulmonary hypertension results from a national prospective registry . Ann Intern Med. 115:1991;343-349.
6. Sandoval J, Bauerle O, Gomez A, Palomar A, Guerra MLM, Furuya ME. Primary pulmonary hypertension in children clinical characterization and survival . J Am Coll Cardiol. 25:1995;466-474.
7. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res. 4:1970;23-30.
8. Cox DR. Regression models and life tables [with discussion]. J R Stat Soc [B]. 34:1972;187-220.
9. Pagano M, Gauvreau K. Principles of Biostatistics. 1993;427-443 Wadsworth, Belmont (CA).
10. Bridges ND, Mallory GB, Huddleston CB, Canter CE, Sweet SC, Spray TL. Lung transplantation in children and young adults with cardiovascular disease. Ann Thorac Surg. 59:1995;813-821.
11. Rabinovitch M, Haworth SG, Castenada AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease a morphometric approach to pulmonary vascular disease . Circulation. 58:1978;1107-1122.
12. Rabinovitch M, Keane JF, Fellows K, Castaneda AR, Reid LM. Quantitative analysis of the pulmonary wedge angiogram in congenital heart defects correlation with hemodynamic data and morphometric findings in lung biopsy tissue . Circulation. 63:1981;152-164.
13. Rabinovitch M, Keane JF, Norwood WI, Castenada AR, Reid LM. Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation. 69:1984;655-667.
14. Wilson NJ, Seear MD, Taylor GP, LeBlanc JG, Sandor GG. The clinical value and risks of lung biopsy in children with congenital heart disease. J Thorac Cardiovasc Surg. 99:1990;460-468.
15. Rubin LJ. Primary pulmonary hypertension. Chest. 104:1993;236-250.
16. Rich S, Kaufman E, Levy PS. The effect of high-dose calcium channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 327:1992;76-81.
17. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frey RL. Primary pulmonary hypertension natural history and the importance of thrombosis . Circulation. 70:1984;580-587.
18. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med. 121:1994;409-415.
19. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 334:1996;296-302.
20. Spray TL, Mallory GB, Canter CE, Huddleston CB, Kaiser LR. Pediatric lung transplantation for pulmonary hypertension and congenital heart disease. Ann Thorac Surg. 54:1992;216-225.
21. Spray TL, Mallory GB, Canter CE, Huddleston CB. Pediatric lung transplantation indications, techniques, and early results . J Thorac Cariovasc Surg. 107:1994;990-1000.
22. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation eleventh official report - 1994 . J Heart Lung Transplant. 13:1994;561-570.
23. Rhodes J, Barst RJ, Garofano RP, Thoele DG, Gersony WM. Hemodynamic correlates of exercise function in patients with primary pulmonary hypertension. J Am Coll Cardiol. 18:1991;1738-1744.
24. Keane JF, Fyler DC, Nadas AS. Hazards of cardiac catheterization in children with primary pulmonary vascular obstruction. Am Heart J. 96:1978;556-557.